Product Images Aripiprazole

This is a description of a medication named Aripiprazole, which comes in tablet form. Each tablet has 30 grams of ipprazol, contained in a unit dose package. The dosage instructions are not available in the text. The medication is prescribed and should be kept out of reach of children.*

This is a description of a medication named Aripiprazole. It comes in a box with the label "ZMAJOR" and a unit dose with 20mg of Aripiprazole per tablet. The recommended dosage should be obtained from prescribing information, directions, and warnings. It must be stored at room temperature. Users must keep the medication out of reach of children. There is no additional relevant information.*

Brand name: ZMAJOR. Each tablet contains 15mg of Aripiprazole. It is a prescription medicine to be sold only by a pharmacist with the accompanying medication guide. Store it between 15-30°C. The packaging is not child-resistant and comes in a unit dose. Manufacturer is not clear.*

This is a medicine called Aripiprazole which comes in the form of tablets. It is only available with a prescription and should be dispensed with a medication guide. The pack contains 100 unit dose tablets. The text mentions usual dosage, product information, prescribing precautions, and warnings. The medicine should be stored within the temperature range of 20-25°C (68-77°F) and it should not be given to children. The rest of the text is illegible due to errors.*

This is a medication package of Aripiprazole Tablets, USP with unit dose and NDC number 0904651061. The package contains 5 gm of Aripiprazole, with instructions, dosage, and warnings. It is advisable to keep the medicine in a container at room temperature. The package includes medication guide, and it's only available with a prescription.*

ARIPIPRAZOLE is a pharmaceutical product available in tablet form with a suggested use only under a doctor's prescription. The tablets are unit dosed or in single-use packages and contain 2mg of arpprazoe. The label of the drug advises keeping it out of the reach of children, storing it between 25°C to 30°C, and being cautious while administering it. The is not able to understand all the characters, so it could not recognize the whole details of the related medication warnings and instructions.*

This is a table that shows the effect of various drugs on Aripiprazole with fold changes and confidence intervals. The drugs include a CYP3A4 inhibitor, a CYP206 inhibitor, gastric acid blockers, and valproate. The table also includes a reference for Aripiprazole without any interacting drugs.*

The text is about the effect of different drugs on aripiprazole. It lists various drugs that either inhibit or induce specific enzymes in the liver responsible for the breakdown of aripiprazole in the body. The drugs mentioned include keloctnazole, quinidine, carbamazepine, famotidine, valproate, lithium, and lorazepam. The table also shows the maximum plasma concentration (cmax) and area under the curve (AUC) for these drugs, which can affect the pharmacokinetics of aripiprazole. The text provides additional information about the fold change and 90% confidence interval in dehydro-aripiprazole relative to the reference.*

This appears to be a table or graph showing the effect of Aripiprazole on the pharmacokinetics (PK) of other drugs. The drugs listed include dextromethorphan, warfarin, omeprazole, lamotrigine, valproate, lithium, lorazepam, venlafaxine, O-desmethylvenlafadne, and escitalopram. The data presented shows the fold change and 90% confidence interval for CYP2D6 PK, with the x-axis showing the relative change to the reference without an interacting drug.*

The given text is not available as there are incomplete words and no meaningful sentences.*

This appears to be a table showing the treatment effectiveness of a medication called Aripiprazole compared to a placebo for relapse prevention. The table shows the number of subjects at risk, and the days from randomization. However, there is not enough context to provide further details or conclusions.*